Esketamine Suppresses Astrocyte-Driven Neuroinflammation in Traumatic Brain Injury via the METTL5/c-Myc/PD-L1. [PDF]
Luo L +11 more
europepmc +1 more source
Effect of Intraoperative Low-Dose Esketamine on Postoperative High-Sensitivity Troponin T in Elderly Patients Undergoing Ivor Lewis Esophagectomy. [PDF]
Zhou H +10 more
europepmc +1 more source
Progress in the Application of Esketamine During the Perioperative Period. [PDF]
Wang JS +8 more
europepmc +1 more source
Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression with Comorbid Autism Spectrum Disorder: Three Case Reports. [PDF]
Guffanti A +5 more
europepmc +1 more source
Intranasal esketamine: real-world clinical practice in treatment-resistant depression and factors associated with treatment response. [PDF]
Baune BT +4 more
europepmc +1 more source
Evaluation of optimal dosage combinations of oral midazolam and esketamine for pediatric preoperative sedation: A randomized, double-blind clinical trial. [PDF]
Xiong H +10 more
europepmc +1 more source
Usage of Ketamine in Treating Resistant Depression: A Promising New Treatment Proven to Restoring Connections in the Brain [PDF]
Lombard, Gina
core +1 more source
Esketamine ameliorates postoperative cognitive dysfunction aggravated by preoperative acute sleep deprivation in aged mice via the TLR4/NF-κB pathway. [PDF]
Han B, Jin F, Zhong Y, Teng J.
europepmc +1 more source
Effective doses of esketamine oral or esketamine intranasal for the prevention of preoperative anxiety in pediatric patients: A randomized double-blind dose-finding trial. [PDF]
Xiong H +10 more
europepmc +1 more source
Ketamine or Esketamine in Special Populations of Patients With Treatment-Resistant Depression. [PDF]
Grabarczyk Ł +3 more
europepmc +1 more source

